Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedFooter now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedRevision history updated to include Revision: v3.5.0 and remove Revision: v3.4.3.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check75 days agoChange DetectedA new revision label v3.4.2 was added and the previous v3.4.1 funding notice text was removed.SummaryDifference0.4%

- Check82 days agoChange DetectedA site-wide notice about funding lapse and operating status was added, and the footer now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.4%

- Check89 days agoChange DetectedThe Record History page now includes a glossary option and color-coded additions and deletions with revision metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.